Rchr
J-GLOBAL ID:201401062632118302   Update date: Apr. 23, 2024

Kosaku Murakami

ムラカミ コウサク | Kosaku Murakami
Affiliation and department:
Job title: Tenure-Track Associate Professor
Other affiliations (1):
Research field  (2): Immunology ,  Allergies and connective tissue disease
Research keywords  (8): Cancer Immunothrapy ,  Autoantibody ,  Dietary Habit ,  Chronic Inflammation ,  Rheumatoid Arthritis ,  immune related adverse events ,  Rheumatology ,  Clinical Immunology
Research theme for competitive and other funds  (7):
  • 2022 - 2025 development of therapeutic strategy for immune related adverse events by immune checkpoint inhivitor by focusing on B lymphocyte
  • 2018 - 2022 関節リウマチ患者の関節破壊評価による関節保護対策と看護プログラムの開発
  • 2017 - 2020 Analyisis of mechanism of recepter for specialized pro-resolving mediator in order to innovation of therapeutic strategy on rheumatoid arthritis
  • 2016 - 2019 Autoantibodies in dermatomyositis-associated interstitial lung disease and establishment of treatment for improved life prognosis
  • 2015 - 2017 Innovation for the therapeutic strategies for Rheumatoid Arthritis based on Specialized pro-resolving lipid mediators
Show all
Papers (129):
  • Takayuki Fujii, Koichi Murata, Hideo Onizawa, Akira Onishi, Masao Tanaka, Kosaku Murakami, Kohei Nishitani, Moritoshi Furu, Ryu Watanabe, Motomu Hashimoto, et al. Management and treatment outcomes of rheumatoid arthritis in the era of biologic and targeted synthetic therapies: evaluation of 10-year data from the KURAMA cohort. Arthritis Research and Therapy. 2024. 26. 1
  • Shintaro Honda, Koichi Murata, Shunsuke Fujibayashi, Bungo Otsuki, Takayoshi Shimizu, Takayuki Fujii, Yaichiro Okuzu, Toshiyuki Kawai, Yutaka Kuroda, Akira Onishi, et al. Effect of high disease activity on spinal sagittal malalignment in patients with rheumatoid arthritis. Journal of neurosurgery. Spine. 2024. 1-9
  • Tomoya Kawakami, Sho Masui, Akira Onishi, Hideo Onizawa, Takayuki Fujii, Kosaku Murakami, Koichi Murata, Masao Tanaka, Takashi Shimada, Shunsaku Nakagawa, et al. Comparison of safety and effectiveness between etanercept biosimilar LBEC0101 and reference in patients with rheumatoid arthritis in real-world data using the KURAMA cohort. Modern rheumatology. 2024
  • Kosaku Murakami, Ryu Watanabe, Toshimitsu Fujisaki, Hiromu Ito, Koichi Murata, Wataru Yamamoto, Takayuki Fujii, Hideo Onizawa, Akira Onishi, Masao Tanaka, et al. Predictive value of baseline concomitant glucocorticoid for abatacept-mediated long-term inhibition of radiographic progression: insights from the KURAMA cohort. Immunological medicine. 2024. 47. 1. 45-51
  • Iku Shirasugi, Akira Onishi, Keisuke Nishimura, Wataru Yamamoto, Kosaku Murakami, Hideo Onizawa, Yuichi Maeda, Kosuke Ebina, Yonsu Son, Hideki Amuro, et al. Association of large joint involvement at the start of biological disease-modifying antirheumatic drugs and Janus kinase inhibitors with disease activity and drug retention in patients with rheumatoid arthritis: The ANSWER cohort study. International journal of rheumatic diseases. 2024. 27. 3. e15097
more...
MISC (266):
  • 村上 孝作. B細胞とirAEの関連. BIO Clinica. 2023. 38. 7. 604-605
  • 村上 孝作, 田中 真生, 大西 輝, 鬼澤 秀夫, 村田 浩一, 藤井 貴之, 山本 渉, 武内 徹, 平松 ゆり, 沖田 康孝, et al. 疫学1:RA/関節型JIAの治療 関節リウマチにおける免疫チェックポイント阻害薬(ICI)投与前後のRA治療内容の変化 関西多施設ANSWERコホートを用いた検討. 日本リウマチ学会総会・学術集会プログラム・抄録集. 2023. 67回. 526-526
  • 田淵 裕也, 別役 翼, 白柏 魅怜, 辻 英輝, 鬼澤 秀夫, 日和 良介, 北郡 宏次, 秋月 修治, 村上 孝作, 中嶋 蘭, et al. 脊椎関節炎-2 成人発症低ホスファターゼ症(HPP)と乾癬性関節炎の合併と考えられた1例. 日本リウマチ学会総会・学術集会プログラム・抄録集. 2023. 67回. 598-598
  • 真本 建司, 橋本 求, 岡野 匡志, 山田 祐太郎, 山田 真介, 渡部 龍, 福本 一夫, 権 好穂, 山本 渉, 村上 孝作, et al. 生物学的製剤 First lineでのTNF阻害薬・IL-6阻害薬・CTLA4-Ig・JAK阻害薬におけるmono therapyの治療成績 ANSWERコホートデータから. 日本リウマチ学会総会・学術集会プログラム・抄録集. 2023. 67回. 603-603
  • 山下 真依, 岡野 隆一, 白杉 郁, 山田 啓貴, 西村 啓佑, 千藤 荘, 上田 洋, 前田 俊恒, 林 申也, 山本 渉, et al. JAK阻害薬-4 tsDMARDsとbDMARDsにより関節リウマチ患者の非炎症性疼痛へ及ぼす効果の比較 関西多施設共同研究ANSWER Cohortを用いた検討. 日本リウマチ学会総会・学術集会プログラム・抄録集. 2023. 67回. 621-621
more...
Lectures and oral presentations  (10):
  • Safety profile of Baricitinib (from the perspective of Onco-rheumatology)
    (2023)
  • Clinical course in rheumatoid arthritis after Immune Checkpoint Inhibitor Administration - The ANSWER cohort study -
    (The 67th Annual Scientific Meeting of the Japan College of Rheumatology 2023)
  • Body mass index exhibits differential efficacy among biologic anti-TNF agents in rheumatoid arthritis - The ANSWER cohort study -
    (The 67th Annual Scientific Meeting of the Japan College of Rheumatology 2023)
  • 免疫チェックポイント阻害薬で加療された 悪性腫瘍合併関節リウマチ6症例の臨床経過
    (第37回日本臨床リウマチ学会 2022)
  • 整形外科の先生に知っておいてもらいたい膠原病・リウマチ性疾患のスクリーニング
    (第31回 日本リウマチ学会近畿支部学術集会 2022)
more...
Education (2):
  • 2005 - 2009 Kyoto University Graduate School of Medicine Department of Rheumatology and Clinical Immunology
  • 1996 - 2002 Kyoto University Faculty of Medicine
Professional career (1):
  • 博士 (京都大学)
Work history (9):
  • 2021/04 - 現在 Kyoto University Division of Clinical Immunology and Cancer Immunotherapy, Center for Cancer Immunotherapy and Immunobiology, Graduate School of Medicine Tenure-Track Associate Professor
  • 2017/04 - 2021/03 Kyoto University Hospital Department of Rheumatology and Cinical Immunology Assistant Professor
  • 2014/08 - 2017/03 Kyoto University Hospital Department of Rheumatology and Clinical Immunology Assistant Professor
  • 2013/06 - 2014/07 Leiden University Medical Center Department of Rheumatology Reseacher
  • 2012/04 - 2013/05 Osaka Red Cross Hospital リウマチ・膠原病内科 Medical Stuff
Show all
Committee career (2):
  • 2023/07 - 2024/09 日本リウマチ学会 近畿支部学術集会プログラム委員会
  • 2022/08 - 2023/08 日本リウマチ学会 近畿支部学術集会プログラム委員会
Association Membership(s) (5):
日本骨免疫学会 ,  THE JAPANESE SOCIETY FOR IMMUNOLOGY ,  THE JAPAN SOCIETY FOR CLINICAL IMMUNOLOGY ,  JAPAN COLLEGE OF RHEUMATOLOGY ,  THE JAPANESE SOCIETY OF INTERNAL MEDICINE
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page